Explaining the Decrease in U.S. Deaths from Coronary Disease, 1980–2000
The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Mortality from coronary heart disease in the United States has decreased substantially in recent decades. We conducted a study to determine how much of this decrease could be explained by the use of medical and surgical treatments as opposed to changes in cardiovascular risk factors. METHODS: We applied a previously validated statistical model, IMPACT, to data on the use and effectiveness of specific cardiac treatments and on changes in risk factors between 1980 and 2000 among U.S. adults 25 to 84 years old. The difference between the observed and expected number of deaths from coronary heart disease in 2000 was distributed among the treatments and risk factors included in the analyses. RESULTS: From 1980 through 2000, the age-adjusted death rate for coronary heart disease fell from 542.9 to 266.8 deaths per 100,000 population among men and from 263.3 to 134.4 deaths per 100,000 population among women, resulting in 341,745 fewer deaths from coronary heart disease in 2000. Approximately 47% of this decrease was attributed to treatments, including secondary preventive therapies after myocardial infarction or revascularization (11%), initial treatments for acute myocardial infarction or unstable angina (10%), treatments for heart failure (9%), revascularization for chronic angina (5%), and other therapies (12%). Approximately 44% was attributed to changes in risk factors, including reductions in total cholesterol (24%), systolic blood pressure (20%), smoking prevalence (12%), and physical inactivity (5%), although these reductions were partially offset by increases in the body-mass index and the prevalence of diabetes, which accounted for an increased number of deaths (8% and 10%, respectively). CONCLUSIONS: Approximately half the decline in U.S. deaths from coronary heart disease from 1980 through 2000 may be attributable to reductions in major risk factors and approximately half to evidence-based medical therapies.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Between 1950 and 1970 most of the decline in mortality rates from CVD was due to prevention (Goldman & Cook, 1984), whereas acute disease management and medical treatments accounted for about half of the decline between 1980 and 2000 (Ford et al., 2007).”
From Mortality and Morbidity Trends: Is There Compression of Morbidity? (2011) · cites this paper as Ford et al., 2007
In the citing paper
“Past studies show the effect of access to high-quality personal health care on both communicable and non-communicable diseases, highlighting the importance of prioritising personal health-care access and quality for all populations across the development spectrum.39–42”
In the citing paper
“Prevention works: .50% of the reductions seen in CHD mortality relate to changes in risk factors, and 40% to improved treatments.”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [29]
In the citing paper
“Another approach to understanding the changes in CVD mortality and incidence rates is by applying models such as the IMPACT mortality model.29 Based on information on changes in coronary risk factors and in treatment as obtained from the results of RCTs regarding the effectiveness of different treatment modalities, it estimates the expected influence on CHD mortality by age and gender.”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [29]
In the citing paper
“Beneficial reductions in major risk factors-in particular smoking, BP, and cholesterol-accounted for more than half of the decrease in CHD deaths, although they were counteracted by an increase in the prevalence of obesity and type 2 diabetes; 40% of the decline in CHD death rates is attributed to better treatments of acute myocardial infarction, heart failure, and other cardiac conditions.”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [29]
9 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Collaboration, A. T. (2002) · BMJ · doi:10.1136/bmj.324.7329.71 · Cited by 6,943
Prevalence of Overweight and Obesity Among US Children, Adolescents, and Adults, 1999-2002
Hedley, A. A. (2004) · JAMA · doi:10.1001/jama.291.23.2847 · Cited by 4,460
Writing Group Members, Thom, T., Haase, N., Rosamond, W., Howard, V. J., Rumsfeld, J., Manolio, T., Zheng, Z.-J., Flegal, K., O’Donnell, C., et al. (2006) · Circulation · doi:10.1161/circulationaha.105.171600 · Cited by 3,451
Rosamond, W., Flegal, K., Friday, G., Furie, K., Go, A., Greenlund, K., Haase, N., Ho, M., Howard, V., Kissela, B., et al. (2007) · Circulation · doi:10.1161/circulationaha.106.179918 · Cited by 3,277
Excess Deaths Associated With Underweight, Overweight, and Obesity
Flegal, K. M. (2005) · JAMA · doi:10.1001/jama.293.15.1861 · Cited by 2,824
Harris, M. I., Flegal, K. M., Cowie, C. C., Eberhardt, M. S., Goldstein, D. E., Little, R. R., Wiedmeyer, H.-M., & Byrd-Holt, D. D. (1998) · Diabetes Care · doi:10.2337/diacare.21.4.518 · Cited by 2,703
A Potential Decline in Life Expectancy in the United States in the 21st Century
Olshansky, S. J., Passaro, D. J., Hershow, R. C., Layden, J., Carnes, B. A., Brody, J., Hayflick, L., Butler, R. N., Allison, D. B., & Ludwig, D. S. (2005) · New England Journal of Medicine · doi:10.1056/nejmsr043743 · Cited by 2,612
Hajjar, I. (2003) · JAMA · doi:10.1001/jama.290.2.199 · Cited by 2,409
A Potential Decline in Life Expectancy in the United States in the 21st Century
Olshansky, S. J., Passaro, D. J., Hershow, R. C., Layden, J., Carnes, B. A., Brody, J., Hayflick, L., Butler, R. N., Allison, D. B., & Ludwig, D. S. (2005) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000167407.83915.e7 · Cited by 1,944
Research works printed but not linked: 3
- 2004, MMWR Morb Mortal Wkly Rep, 53, 82
- Ryan R, 2001, Health Stat Q, 12, 34
- Mokdad AH, 2003, MMWR Recomm Rep, 52, 1
Cited by
Items 701–800 of 1,006
La promoción de la salud general y la salud oral: una estrategia conjunta
Rengifo, A. C. (2016) · Revista clínica de periodoncia implantología y rehabilitación oral · doi:10.1016/j.piro.2016.07.003 · Cited by 100
Burke, G. M., Genuardi, M. V., Shappell, H. M., D’Agostino, R. B., & Magnani, J. W. (2017) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2017.07.087 · Cited by 43
Sparrow, R. T., Khan, A. M., Legere, L., Ko, D. T., Jackevicius, C. A., Goodman, S. G., Anderson, T. J., Stacey, D., Tiszovszky, I., Farkouh, M. E., et al. (2019) · JAMA Cardiology · doi:10.1001/jamacardio.2019.3066 · Cited by 44
Sleep inflammation and cardiovascular disease
Meier-Ewert, H. K. (2012) · Frontiers in Bioscience · doi:10.2741/e560 · Cited by 43
Design and execution of clinical trials in orthopaedic surgery
Mundi, R., Chaudhry, H., Mundi, S., Godin, K. M., & Bhandari, M. (2014) · Bone and Joint Research · doi:10.1302/2046-3758.35.2000280 · Cited by 45
Patel, D. N., Lambert, E. V., da Silva, R., Greyling, M., Nossel, C., Noach, A., Derman, W. E., & Gaziano, T. A. (2010) · American Journal of Health Promotion · doi:10.4278/090217-quan-68r2.1 · Cited by 50
Does surveillance impact on cardiovascular prevention?
Di Chiara, A., & Vanuzzo, D. (2009) · European Heart Journal · doi:10.1093/eurheartj/ehp025 · Cited by 42
Saleh, Z. T., Elshatarat, R. A., Elhefnawy, K. A., Elneblawi, N. H., Raddaha, A. H. A., Al-Za'areer, M. S., Almarwani, A. M., Alzahrani, N. S., Aqel, A. A., Shawashi, T. O., et al. (2022) · The Journal of Cardiovascular Nursing · doi:10.1097/jcn.0000000000000911 · Cited by 45
Gijsberts, C., Seneviratna, A., de Carvalho, L. P., den Ruijter, H. D., Vidanapthirana, P., Sorokin, V., Stella, P., Agostoni, P., Asselbergs, F., Richards, A., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0132278 · Cited by 39
Lundqvist, C. B., Auricchio, A., Brugada, J., Boriani, G., Bremerich, J., Cabrera, J. Á., Frank, H., Gutberlet, M., Heidbüchel, H., Kück, K., et al. (2013) · EP Europace · doi:10.1093/europace/eut084 · Cited by 43
Economic Costs and Benefits of Healthy Eating
Anekwé, T. D., & Rahkovsky, I. M. (2013) · Current Obesity Reports · doi:10.1007/s13679-013-0064-9 · Cited by 45
Modig, K., Andersson, T., Drefahl, S., & Ahlbom, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064928 · Cited by 49
Tong, L., Ahn, C. W., Symanski, E., Lai, D., & Du, X. L. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu131 · Cited by 42
Recent Trends in Hospitalization for Acute Myocardial Infarction
Wang, O. J., Wang, Y., Chen, J., & Krumholz, H. M. (2012) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2012.01.381 · Cited by 42
Buikema, J. W., van der Meer, P., Sluijter, J. P. G., & Domian, I. J. (2013) · Stem Cells · doi:10.1002/stem.1467 · Cited by 44
Jouni, H., Askew, J. W., Crusan, D. J., Miller, T. D., & Gibbons, R. J. (2016) · American Heart Journal · doi:10.1016/j.ahj.2016.03.014 · Cited by 42
Tu, J. V., Khan, A. M., Ng, K., & Chu, A. (2016) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2016.11.009 · Cited by 45
Chen, Q., Zhang, Y., Ding, D., Li, D., Yang, Y., Li, Q., Chen, X., Hu, G., & Ling, W. (2017) · European Journal of Nutrition · doi:10.1007/s00394-017-1518-8 · Cited by 48
Obesity and trends in cardiovascular risk factors over 40 years in Swedish men aged 50
Rosengren, A., Eriksson, H., Hansson, P., Svärdsudd, K., Wilhelmsen, L., Johansson, S., Welin, C., & Welin, L. (2009) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2009.02116.x · Cited by 46
Brown, T. M., Parmar, G. M., Durant, R. W., Halanych, J. H., Hovater, M. K., Muntner, P., Prineas, R. J., Roth, D. L., Samdarshi, T. E., & Safford, M. M. (2011) · Journal of Health Care for the Poor and Underserved · doi:10.1353/hpu.2011.0127 · Cited by 44
The clustering of Cardiovascular, Renal, Adipo-Metabolic Eye and Liver disease with type 2 diabetes
Thomas, M. C. (2022) · Metabolism · doi:10.1016/j.metabol.2021.154961 · Cited by 41
Patients with Diabetes in Cardiac Rehabilitation: Attendance and Exercise Capacity
ARMSTRONG, M. J., MARTIN, B.-J., ARENA, R., HAUER, T. L., AUSTFORD, L. D., STONE, J. A., AGGARWAL, S., & SIGAL, R. J. (2014) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0000000000000189 · Cited by 41
Estrogen signaling as a bridge between the nucleus and mitochondria in cardiovascular diseases
Guajardo-Correa, E., Silva-Agüero, J. F., Calle, X., Chiong, M., Henríquez, M., García‐Rivas, G., Latorre, M., & Parra, V. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.968373 · Cited by 47
Williams, K. J. (2023) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.123.320065 · Cited by 47
Boden, W. E., Caterina, R. D., Kaski, J. C., Merz, C. N. B., Berry, C., Marzilli, M., Pepine, C. J., Barbato, E., Stefanini, G. G., Prescott, E., et al. (2024) · European Heart Journal · doi:10.1093/eurheartj/ehae278 · Cited by 48
Isoflavones for hypercholesterolaemia in adults
Qin, Y., Niu, K., Zeng, Y., Liu, P., Yi, L., Zhang, T., Zhang, Q. Y., Zhu, J. D., & Mi, M. T. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009518.pub2 · Cited by 44
Mass spectrometry for the evaluation of cardiovascular diseases based on proteomics and lipidomics
Thomas, A., Lenglet, S., Chaurand, P., Déglon, J., Mangin, P. J., Mach, F., Steffens, S., Wolfender, J., & Staub, C. (2011) · Thrombosis and Haemostasis · doi:10.1160/th10-12-0812 · Cited by 44
Ji, Q., Zhao, H., Mei, Y., Shi, Y., Ma, R., & Ding, W. (2015) · Journal of Cardiothoracic Surgery · doi:10.1186/s13019-015-0216-y · Cited by 41
Ogagarue, E. R., Lutsey, P. L., Klein, R., Klein, R., & Folsom, A. R. (2013) · Journal of the American Heart Association · doi:10.1161/jaha.113.000430 · Cited by 46
Vulnerable Plaques and Patients: Improving Prediction of Future Coronary Events
Ambrose, J. A., & Srikanth, S. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.07.019 · Cited by 42
Neubeck, L., Freedman, B., Briffa, T. G., Bauman, A. E., & Redfern, J. (2011) · European Journal of Cardiovascular Prevention & Rehabilitation · doi:10.1097/hjr.0b013e32833cca66 · Cited by 43
Slowing Progress in Cardiovascular Mortality Rates: You Reap What You Sow
Lloyd-Jones, D. M. (2016) · JAMA Cardiology · doi:10.1001/jamacardio.2016.1348 · Cited by 41
Association of tobacco use and cessation with coronary atherosclerosis
Cheezum, M. K., Kim, A., Bittencourt, M. S., Kassop, D., Nissen, A. P., Thomas, D. M., Nguyen, B. T., Glynn, R. J., Shah, N. R., & Villines, T. C. (2016) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2016.11.016 · Cited by 43
Collet, J., Cayla, G., Ennezat, P., Leclercq, F., Cuisset, T., Elhadad, S., Henry, P., Belle, L., Cohen, A. A., Silvain, J., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.11.081 · Cited by 41
Kim, E. J., Kressin, N. R., Paasche‐Orlow, M. K., López, L., Rosen, J. E., Lin, M., & Hanchate, A. D. (2018) · BMC Health Services Research · doi:10.1186/s12913-018-3180-0 · Cited by 43
Age- and sex-specific trends in the incidence of myocardial infarction in Denmark, 2005 to 2021
Christensen, D. M., Strange, J. E., Phelps, M. D., Schjerning, A. M., Sehested, T. S. G., Gerds, T. A., & Gislason, G. (2022) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2022.03.003 · Cited by 47
Canning, D., & H, D. B. M. P. (2010) · Social Science & Medicine · doi:10.1016/j.socscimed.2010.07.009 · Cited by 50
Tobias, M. I., Taylor, R. J., Yeh, L., Huang, K., Mann, S., & Sharpe, N. (2008) · Australian and New Zealand Journal of Public Health · doi:10.1111/j.1753-6405.2008.00186.x · Cited by 41
Secular trends in acute coronary syndrome hospitalization from 1994 to 2005
Ko, D. T., Newman, A. M., Alter, D. A., Austin, P. C., Chiu, M., Cox, J. L., Goodman, S. G., & Tu, J. V. (2010) · Canadian Journal of Cardiology · doi:10.1016/s0828-282x(10)70350-0 · Cited by 41
Clinical determinants of ischemic heart disease in Eastern Europe
Cenko, E., Manfrini, O., Fabin, N., Dorobanţu, M., Kedev, S. A., Miličić, D., Vasiljević, Z., & Bugiardini, R. (2023) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2023.100698 · Cited by 52
Genetic insights into cardiometabolic risk factors.
Whitfield, J. B. (2014) · Europe PMC (PubMed Central) · Cited by 53
Frank, J. W., & Haw, S. J. (2011) · Milbank Quarterly · doi:10.1111/j.1468-0009.2011.00646.x · Cited by 44
Global mortality trends and patterns in older women
Stevens, G. A., Mathers, C. D., & Beard, J. (2013) · Bulletin of the World Health Organization · doi:10.2471/blt.12.109710 · Cited by 50
Transforming Clinical Trials in Cardiovascular Disease
Antman, E. M., & Harrington, R. A. (2012) · JAMA · doi:10.1001/jama.2012.14841 · Cited by 40
26 Years of LDL – Apheresis: A review of experience
Borberg, H. (2009) · Transfusion and Apheresis Science · doi:10.1016/j.transci.2009.05.013 · Cited by 40
Renal Dysfunction Potentiates Foam Cell Formation by Repressing ABCA1
Zuo, Y., Yancey, P., Castro, I., Khan, W., Motojima, M., Ichikawa, I., Fogo, A. B., Linton, M. F., Fazio, S., & Kon, V. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.109.188995 · Cited by 39
Robinson, J. G., & Booth, B. (2010) · Journal of Clinical Lipidology · doi:10.1016/j.jacl.2010.10.002 · Cited by 38
Policing and public health: Not quite the right analogy
Anderson, E. D., & Burris, S. C. (2016) · Policing & Society · doi:10.1080/10439463.2016.1231188 · Cited by 42
Ogata, S., Nishimura, K., Guzman-Castillo, M., Sumita, Y., Nakai, M., Nakao, Y. M., Nishi, N., Noguchi, T., Sekikawa, A. M., Saito, Y., et al. (2019) · International Journal of Cardiology · doi:10.1016/j.ijcard.2019.02.022 · Cited by 40
Self-citationPredictors of all-cause 1-year mortality in myocardial infarction patients
Ye, Q., Zhang, J., & Ma, L. (2020) · Medicine · doi:10.1097/md.0000000000021288 · Cited by 40
Bartels, C. M., Johnson, H. M., Voelker, K. A., Thorpe, C. T., McBride, P. E., Jacobs, E. A., Pandhi, N., & Smith, M. A. (2014) · Arthritis Care & Research · doi:10.1002/acr.22302 · Cited by 40
Adolescence BMI and Trends in Adulthood Mortality: A Study of 2.16 Million Adolescents
Twig, G., Afek, A., Shamiss, A., Derazne, E., Landau Rabbi, M., Tzur, D., Gordon, B., & Tirosh, A. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1213 · Cited by 39
Papadakis, S., & Moroz, I. (2008) · Current Opinion in Cardiology · doi:10.1097/hco.0b013e32830c217e · Cited by 40
Pandya, A., Sy, S., Cho, S., Alam, S., Weinstein, M. C., & Gaziano, T. A. (2017) · Medical Decision Making · doi:10.1177/0272989x17706081 · Cited by 44
Cohort profile: the Emory Cardiovascular Biobank (EmCAB)
Ko, Y., Hayek, S. S., Sandesara, P. B., Tahhan, A. S., & Quyyumi, A. A. (2017) · BMJ Open · doi:10.1136/bmjopen-2017-018753 · Cited by 41
Murthy, V. L., & Carli, M. F. D. (2012) · Journal of Nuclear Cardiology · doi:10.1007/s12350-012-9590-1 · Cited by 40
Becker, R. C., Scheiman, J. M., Dauerman, H. L., Spencer, F. A., Rao, S. V., Sabatine, M. S., Johnson, D. A., Chan, F., Abraham, N. S., & Quigley, E. M. M. (2009) · The American Journal of Gastroenterology · doi:10.1038/ajg.2009.667 · Cited by 41
Reducing cardiovascular disease risk in medically underserved urban and rural communities
Bové, A. A., Santamore, W. P., Homko, C. J., Kashem, A. M., Cross, R. C., McConnell, T. R., Shirk, G., & Menapace, F. J. (2011) · American Heart Journal · doi:10.1016/j.ahj.2010.11.008 · Cited by 39
Wellenius, G. A., & Mittleman, M. A. (2008) · American Heart Journal · doi:10.1016/j.ahj.2008.04.009 · Cited by 39
Modesti, P. A., Bianchi, S., Borghi, C., Cameli, M., Capasso, G., Ceriello, A., Ciccone, M. M., Germanò, G., Maiello, M. R., Muiesan, M. L., et al. (2014) · Journal of Cardiovascular Medicine · doi:10.2459/jcm.0000000000000069 · Cited by 47
García‐Ríos, A., Alcala-Diaz, J. F., Gómez-Delgado, F., Delgado‐Lista, J., Marín, C., Leon‐Acuña, A., Camargo, A., Rodríguez-Cantalejo, F., Blanco-Rojo, R., Quintana‐Navarro, G. M., et al. (2016) · Clinical Nutrition · doi:10.1016/j.clnu.2016.12.011 · Cited by 41
Identifying the Critical Gaps in Research on Sex Differences in Metabolism Across the Life Span
Reusch, J. E. B., Kumar, T. R., Regensteiner, J. G., Zeitler, P. S., Participants, C., Arany, Z. P., Merz, C. N. B., Barrett-Connor, E. L., Boyle, K. E., Brown, L., et al. (2017) · Endocrinology · doi:10.1210/en.2017-03019 · Cited by 42
Impact of High Deductible Health Plans on Cardiovascular Medication Adherence and Health Disparities
Lewey, J., Gagne, J. J., Franklin, J. M., Lauffenburger, J. C., Brill, G. E., & Choudhry, N. K. (2018) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.118.004632 · Cited by 41
Statins for the Primary Prevention of Coronary Heart Disease
Li, M., Wang, X., Li, X., Chen, H., Hu, Y., Zhang, X., Tang, X., Miao, Y., Tian, G., & Shang, H. (2019) · BioMed Research International · doi:10.1155/2019/4870350 · Cited by 43
Yan, J., Lin, H.-H., Zhao, D., Yuanjia, H., & Shao, R. (2019) · BMC Health Services Research · doi:10.1186/s12913-019-3921-8 · Cited by 39
Asri, A. K., Yu, C.-P., Pan, W., Guo, Y. L., Su, H.-J. J., Lung, S. C., Wu, C., & Spengler, J. D. (2020) · Environmental Research Letters · doi:10.1088/1748-9326/abbbaf · Cited by 41
Expression of Apolipoprotein A-I in Rabbit Carotid Endothelium Protects Against Atherosclerosis
Flynn, R., Qian, K., Tang, C., Dronadula, N., Buckler, J. M., Jiang, B., Wen, S., Dichek, H. L., & Dichek, D. A. (2011) · Molecular Therapy · doi:10.1038/mt.2011.133 · Cited by 40
Saito, I., Kokubo, Y., Yamagishi, K., Iso, H., Inoue, M., & Tsugane, S. (2011) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2011.01.021 · Cited by 38
Bartels, E. D., Nielsen, J. M., Hellgren, L. I., Ploug, T., & Nielsen, L. B. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005300 · Cited by 41
Hamm, C. W., Bassand, J., Agewall, S., Bax, J. J., Boersma, E. H., Bueno, H., Caso, P., Dudek, D., Gielen, S., Huber, K., et al. (2012) · Revista Española de Cardiología · doi:10.1016/j.recesp.2011.11.006 · Cited by 64
Dalcetrapib: a review of Phase II data
Robinson, J. G. (2010) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2010.488219 · Cited by 38
Ketchum, E. S., Dickstein, K., KJEKSHUS, J. K., Pitt, B., Wong, M. F., Linker, D. T., & Levy, W. C. (2013) · European Heart Journal Acute Cardiovascular Care · doi:10.1177/2048872613502283 · Cited by 40
Interleukin-1 Blockade in Cardiovascular Diseases: From Bench to Bedside
Buckley, L. F., & Abbate, A. (2018) · BioDrugs · doi:10.1007/s40259-018-0274-5 · Cited by 38
Explaining The Slowdown In Medical Spending Growth Among The Elderly, 1999–2012
Cutler, D. M., Ghosh, K., Messer, K. L., Raghunathan, T. E., Stewart, S. T., & Rosen, A. B. (2019) · Health Affairs · doi:10.1377/hlthaff.2018.05372 · Cited by 36
Stolpe, S., Kowall, B., & Stang, A. (2020) · European Journal of Epidemiology · doi:10.1007/s10654-020-00699-0 · Cited by 38
Shah, A. S. V., Lee, K. K., Pérez, J. A. R., Campbell, D., Astengo, F., Logue, J., Gallacher, P. J., Katikireddi, S. V., Bing, R., Alam, S. R., et al. (2021) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2021.100141 · Cited by 52
An Integrated Approach to the Diagnosis and Treatment of Anxiety Within the Practice of Cardiology
Janeway, D. (2009) · Cardiology in Review · doi:10.1097/crd.0b013e3181867fe3 · Cited by 38
Acosta-Cázares, B., & Escobedo, J. (2010) · American Heart Journal · doi:10.1016/j.ahj.2010.05.016 · Cited by 39
Gender‐specific aspects in the clinical presentation of cardiovascular disease
Leuzzi, C., Sangiorgi, G., & Modena, M. G. (2010) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2010.00873.x · Cited by 43
Update on breast cancer risk prediction and prevention
Šestak, I., & Cuzick, J. M. (2014) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0000000000000153 · Cited by 39
Andrikopoulos, G. K., Tzeis, S. E., Nikas, N., Richter, D. J., Pipilis, A. G., Gotsis, A., Tsaknakis, T., Kartalis, A. N., Kitsiou, A. N., Toli, K., et al. (2012) · International Journal of Cardiology · doi:10.1016/j.ijcard.2012.10.049 · Cited by 38
Bundhun, P. K., Wu, Z. J., & Chen, M. (2015) · Medicine · doi:10.1097/md.0000000000002313 · Cited by 46
Explaining the Decline in Coronary Heart Disease Mortality in the Netherlands between 1997 and 2007
Koopman, C., Vaartjes, I. C. H., van Dis, I., Verschuren, W. M. M., Engelfriet, P. M., Heintjes, E. M., Blokstra, A., Deeg, D. J. H., Visser, M., Bots, M. L., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0166139 · Cited by 42
Self-citationMicroRNA and Diabetic Complications: A Clinical Perspective
Fan, B., Luk, A. O. Y., Chan, J. C. N., & Ronald, C. W. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7318 · Cited by 38
Mechanisms of the “No-Reflow” Phenomenon After Acute Myocardial Infarction
Kaul, S., Methner, C., Cao, Z., & Mishra, A. (2022) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2022.06.008 · Cited by 37
Tafolecimab in Chinese Patients With Hypercholesterolemia (CREDIT-4)
Qi, L., Liu, D., Qu, Y., Chen, B., Meng, H., Zhu, L., Li, L., Wang, S., Liu, C., Zheng, G., et al. (2023) · JACC Asia · doi:10.1016/j.jacasi.2023.04.011 · Cited by 40
Fan, Q., Huang, Z. M., Boucher, M., Shang, X., Zuo, L., Brinks, H., Lau, W. B., Zhang, J., Chuprun, J. K., & Gao, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0073537 · Cited by 37
Efficient design of clinical trials and epidemiological research: is it possible?
Lauer, M. S., Gordon, D., Wei, G. S., & Pearson, G. D. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.60 · Cited by 40
Recent Advances in Coronary Artery Bypass Grafting Techniques and Outcomes: A Narrative Review
Thakare, V. S., Sontakke, N. G., Wasnik, P., & Kanyal, D. (2023) · Cureus · doi:10.7759/cureus.45511 · Cited by 36
Forouzesh, A., Forouzesh, F., Foroushani, S. S., & Forouzesh, A. (2025) · Food Production Processing and Nutrition · doi:10.1186/s43014-025-00306-3 · Cited by 36
Landmark Lipid‐Lowering Trials in the Primary Prevention of Cardiovascular Disease
Chrispin, J., Martin, S. S., Hasan, R. K., Joshi, P. H., Minder, C. M., McEvoy, J. W., Kohli, P., Johnson, A. E., Wang, L., Blaha, M. J., et al. (2013) · Clinical Cardiology · doi:10.1002/clc.22147 · Cited by 35
Hughes, J., Kee, F., O’Flaherty, M., Critchley, J., Cupples, M., Capewell, S., & Bennett, K. (2012) · European Journal of Preventive Cardiology · doi:10.1177/2047487312441725 · Cited by 42
Self-citationZhong, Y., Rosengren, A., Fu, M. L. X., Welin, L., Welin, C., Caidahl, K., Mandalenakis, Z., Dellborg, M., Svärdsudd, K., & Hansson, P. (2016) · European Journal of Preventive Cardiology · doi:10.1177/2047487316676905 · Cited by 38
Reyes‐Aldasoro, C. C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0173671 · Cited by 36
Intensive Cardiac Rehabilitation: an Underutilized Resource
Freeman, A. M., Taub, P. R., Lo, H. C., & Ornish, D. M. (2019) · Current Cardiology Reports · doi:10.1007/s11886-019-1104-1 · Cited by 36
Gaur, K., Mohan, I., Kaur, M., Ahuja, S., Gupta, S., & Gupta, R. (2020) · American Journal of Preventive Cardiology · doi:10.1016/j.ajpc.2020.100035 · Cited by 36
van Velzen, T. J., Kuhrij, L. S., Westendorp, W. F., van de Beek, D., & Nederkoorn, P. J. (2021) · BMC Neurology · doi:10.1186/s12883-020-02032-4 · Cited by 38
Jafar, T. H., Tan, N. C., Shirore, R. M., Allen, J. C., Finkelstein, E. A., Hwang, S. W., Koong, A. Y. L., Moey, P. K. S., Kang, G. C.-Y., Goh, C. W. T., et al. (2022) · PLoS Medicine · doi:10.1371/journal.pmed.1004026 · Cited by 38
Khosravi, A., Kelishadi, R., Sarrafzadegan, N., Boshtam, M., Nouri, F., Zarfeshani, S., & Esmaillzadeh, A. (2012) · Europe PMC (PubMed Central) · Cited by 36
Clinical Effects of Hypertension on the Mortality of Patients with Acute Myocardial Infarction
Kang, D. G., Jeong, M. H., Ahn, Y., Chae, S. C., Hur, S., Hong, T. J., Kim, Y. J., Seong, I. W., Chae, J. K., Rhew, J. Y., et al. (2009) · Journal of Korean Medical Science · doi:10.3346/jkms.2009.24.5.800 · Cited by 36
Metadata
- Authors
- Ford, E. S., Ajani, U. A., Croft, J. B., Critchley, J. A., Labarthe, D. R., Kottke, T. E., Giles, W. H., & Capewell, S.
- Affiliations
- Centers for Disease Control and Prevention (US)
- Newcastle University (GB)
- HealthPartners (US)
- University of Liverpool (GB)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-06-07
- Volume
- 356
- Issue
- 23
- Pages
- 2388-2398
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2150278133
- Cited by
- 2,757
- References
- 44
- Citations by year
- 2026: 56 · 2025: 66 · 2024: 60 · 2023: 82 · 2022: 100 · 2021: 101 · 2020: 114 · 2019: 129 · 2018: 129 · 2017: 153 · 2016: 163 · 2015: 209 · 2014: 173 · 2013: 198 · 2012: 252
- FWCI
- 127.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Epidemiology › Healthcare Systems and Public Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
- Keywords
- coronary heart disease mortality, mortality decline, cardiovascular risk factors, IMPACT model, secondary prevention after myocardial infarction, revascularization, acute myocardial infarction treatment, unstable angina, heart failure treatment, cholesterol lowering, blood pressure reduction, smoking, physical inactivity, body mass index, diabetes mellitus, sex differences in mortality
- MeSH terms
- Adult, Aged, Aged, 80 and over, Coronary Disease, Female, Humans, Male, Middle Aged, Mortality, Myocardial Infarction, Myocardial Revascularization, Risk Factors, United States
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.